Showing results (221-230 of 254) with videos related to
Sort By:
Pageof 26
Clinical Pharmacology and Therapeutics|October 24, 2001
Ethnicity influences morphine pharmacokinetics and pharmacodynamicsM S Cepeda, J T Farrar, J H Roa, et al.Addictive Behaviors|July 1, 1994
Prevalence, patterns, and correlates of spit tobacco use in a college athlete populationM M Walsh, J F Hilton, V L Ernster, et al.Meat Science|November 9, 2011
Effect of Dietary Supplementation with α-Tocopheryl Acetate on the Stability of Reformed and Restructured Low Nitrite Cured Turkey ProductsM M Walsh, J F Kerry, D J Buckley, et al.Endocrinology|February 1, 1983
The effects of cysteamine on thyrotropin and immunoreactive beta-endorphin secretion in the ratW J Millard, S M Sagar, T M Badger, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|May 1, 1985
Endogenous opioids and ventilatory responses to hypercapnia in normal humansS E Weinberger, R A Steinbrook, D B Carr, et al.Clinical Pharmacology and Therapeutics|March 3, 2007
Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategiesM A Andrew, T R Easterling, D B Carr, et al.Journal of Microbiological Methods|December 1, 1999
Species-specific detection of hydrocarbon-utilizing bacteriaV L Wilson, B C Tatford, X Yin, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2009
Clonidine pharmacokinetics in pregnancyM L Buchanan, T R Easterling, D B Carr, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 2000
A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesicS E Foran, D B Carr, A W Lipkowski, et al.The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Inhibition of morphine tolerance development by a substance P-opioid peptide chimeraS E Foran, D B Carr, A W Lipkowski, et al.Pageof 26